Request Legal Help Now - Free


FDA Grants Hearing for Drugmaker over Avastin Injection

. By
Washington, DCThe US Food and Drug Administration (FDA) recently granted Swiss drugmaker Roche an opportunity to have a public hearing in defense of its Avastin injection for the treatment of breast cancer, The Associated Press reports.

span itemprop="image" itemscope itemtype="" style="display:block">According to the news provider, Roche said recently that it will defend the drug as a breast cancer treatment at a two-day hearing in June. Avastin, the best-selling cancer drug in the world, has received FDA approval to treat a number of other forms of cancer including of the lung, colon and brain.

However, in December, the FDA ruled that studies could not conclusively demonstrate that the medication was effective in extending or improving the lives of patients suffering from breast cancer and sought to revoke approval for such treatment, the news source said.

Still, Roche's chief medical officer, Hal Barron, said in a statement that the drug should remain approved by the FDA for treating the condition.

"We believe Avastin is an important option for women with this disease and should remain an FDA-approved choice," he said.

Roche, which was founded in 1896, sells products in more than 150 countries, according to the company's Web site.


Avastin Legal Help

If you or a loved one have suffered losses in this case, please click the link below and your complaint will be sent to a drugs & medical lawyer who may evaluate your Avastin claim at no cost or obligation.


Please read our comment guidelines before posting.

Note: Your name will be published with your comment.

Your email will only be used if a response is needed.

Are you the defendant or a subject matter expert on this topic with an opposing viewpoint? We'd love to hear your comments here as well, or if you'd like to contact us for an interview please submit your details here.

Click to learn more about

Request Legal Help Now! - Free